GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Total Liabilities

Mizuho Medy Co (TSE:4595) Total Liabilities : 円2,833 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Total Liabilities?

Mizuho Medy Co's Total Liabilities for the quarter that ended in Jun. 2024 was 円2,833 Mil.

Mizuho Medy Co's quarterly Total Liabilities declined from Dec. 2023 (円3,272.35 Mil) to Mar. 2024 (円3,219.00 Mil) and declined from Mar. 2024 (円3,219.00 Mil) to Jun. 2024 (円2,833.00 Mil).

Mizuho Medy Co's annual Total Liabilities increased from Dec. 2021 (円4,164.32 Mil) to Dec. 2022 (円4,819.37 Mil) but then declined from Dec. 2022 (円4,819.37 Mil) to Dec. 2023 (円3,272.35 Mil).


Mizuho Medy Co Total Liabilities Historical Data

The historical data trend for Mizuho Medy Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Total Liabilities Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,612.86 2,268.12 4,164.32 4,819.37 3,272.35

Mizuho Medy Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,623.80 2,995.41 3,272.35 3,219.00 2,833.00

Mizuho Medy Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mizuho Medy Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2279.427+(0+0.0029999999998154
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+992.92)
=3,272

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=18948.138-15675.788
=3,272

Mizuho Medy Co's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1782+(0+3
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1048)
=2,833

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=18663-15830
=2,833

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co Headlines

No Headlines